Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted quantum dot conjugates for siRNA delivery.

Austin M Derfus1, Alice A Chen, Dal-Hee Min

  • 1Department of Bioengineering, University of California at San Diego, La Jolla, California 92093, USA.

Bioconjugate Chemistry
|July 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the αvβ5 Integrin Modifies the TGF-β-Rich Tumor Microenvironment of Pancreatic Cancer.

Cancer research·2026
Same author

Nickel Single-Atom Nanozyme for Multimodal Cancer Therapy.

ACS applied materials & interfaces·2026
Same author

Modulation of Peptoid Nanostructure for Antibiofilm Hydrogel Interfaces.

Nano letters·2026
Same author

Graphene oxide-based fluorescent biosensor for high-throughput screening to discover SARS-CoV-2 RdRp inhibitors.

Journal of materials chemistry. B·2026
Same author

Glioblastoma Immunotherapy Adjuvants for Glial Cell Polarization Regulation.

Experimental neurobiology·2025
Same author

A neuroprotective tetrapeptide for treatment of acute traumatic brain injury.

EMBO molecular medicine·2025

This study developed a nanoparticle platform for targeted cancer therapy and imaging. Quantum dots carrying small interfering RNA (siRNA) and homing peptides effectively targeted tumor cells, enabling gene silencing and potential for metastatic cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Molecular Biology

Background:

  • Current cancer treatment relies on separate diagnostic and therapeutic steps.
  • Nanoparticle platforms offer combined therapeutic and imaging capabilities, improving drug delivery and targeting.
  • Systemic delivery of small interfering RNA (siRNA) therapeutics is challenging due to rapid excretion and off-target distribution.

Purpose of the Study:

  • To develop a multifunctional nanoparticle platform for targeted delivery of siRNA therapeutics.
  • To integrate diagnostic imaging and therapeutic functions into a single nanocarrier.
  • To overcome challenges in siRNA delivery for potential cancer treatment.

Main Methods:

  • Utilized PEGlyated quantum dots (QDs) as a scaffold for conjugating siRNA and tumor-homing peptides (F3).

Related Experiment Videos

  • Investigated the role of conjugation chemistry (disulfide vs. thioether linkages) on siRNA efficacy.
  • Optimized the formulation by balancing the number of homing peptides and siRNA per particle.
  • Evaluated targeted internalization and gene silencing in EGFP-transfected HeLa cells.

    • Main Results:

    • The homing peptide was essential for targeted internalization of nanoparticles by tumor cells.
    • Co-attachment of siRNA did not impede the function of the homing peptide.
    • Disulfide cross-linkers resulted in greater siRNA silencing efficiency compared to thioether linkages.
    • Optimized F3/siRNA-QD formulations demonstrated significant EGFP knockdown in targeted cells.

    Conclusions:

    • The developed multifunctional nanoparticle platform successfully delivers siRNA for targeted gene silencing.
    • This technology holds promise for simultaneous diagnosis and treatment of metastatic cancer.
    • Further adaptation for therapeutic targets like oncogenes could revolutionize cancer therapy.